Latest Iron overload Stories
JADENU(TM), recently FDA-approved to treat chronic iron overload, will be available for patients through Diplomat, the nation's largest independent specialty pharmacy FLINT, Mich.,
- Jadenu (deferasirox), a new formulation of Exjade (deferasirox), is the only once-daily oral tablet for iron chelation EAST HANOVER, N.J., March 30, 2015 /PRNewswire/ -- Novartis announced
The Georgia Health Policy Center (GHPC) at Georgia State University has received a five-year, $2,669,903 award from the U.S.
Author, nutritionist Trisha O’Connor elaborates on connection between the two diseases London, Canada (PRWEB) September 09, 2014 “Hereditary Hemochromatosis?
- Patient safety and well-being are highest priority at Novartis Pharmaceuticals Corporation (NPC) EAST HANOVER, N.J., Jan.
Treatment for sickle cell disease has largely focused on managing pain and acute complications, but current research, including several projects at Texas Children’s Hematology Center, is now aimed at developing more efficient and progressive forms of treatment that could potentially benefit patients around the world.
Resonance Health is pleased to announce the peer reviewed publication of a significant validation study for FerriScan R2-MRI. (PRWEB) July 09, 2013 FerriScan